Literature DB >> 23866811

Use of virulence determinants and seropathotypes to distinguish high- and low-risk Escherichia coli O157 and non-O157 isolates from Europe.

M F Anjum1, E Jones1, V Morrison1, R Tozzoli2, S Morabito2, I Toth3, B Nagy3, G Smith4, A Aspan5, E M Nielsen6, P Fach7, S Herrera-León8, M J Woodward1, R M LA Ragione1.   

Abstract

The presence of 10 virulence genes was examined using polymerase chain reaction (PCR) in 365 European O157 and non-O157 Escherichia coli isolates associated with verotoxin production. Strain-specific PCR data were analysed using hierarchical clustering. The resulting dendrogram clearly separated O157 from non-O157 strains. The former clustered typical high-risk seropathotype (SPT) A strains from all regions, including Sweden and Spain, which were homogenous by Cramer's V statistic, and strains with less typical O157 features mostly from Hungary. The non-O157 strains divided into a high-risk SPTB harbouring O26, O111 and O103 strains, a group pathogenic to pigs, and a group with few virulence genes other than for verotoxin. The data demonstrate SPT designation and selected PCR separated verotoxigenic E. coli of high and low risk to humans; although more virulence genes or pulsed-field gel electrophoresis will need to be included to separate high-risk strains further for epidemiological tracing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23866811      PMCID: PMC9161224          DOI: 10.1017/S0950268813001635

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  30 in total

1.  Genotypic characterization to identify markers associated with putative hypervirulence in Swedish Escherichia coli O157:H7 cattle strains.

Authors:  E Eriksson; R Söderlund; S Boqvist; A Aspan
Journal:  J Appl Microbiol       Date:  2010-11-15       Impact factor: 3.772

2.  Verocytotoxin-producing and attaching and effacing activity of Escherichia coli isolated from diseased farm livestock.

Authors:  J P Hutchinson; T E A Cheney; R P Smith; K Lynch; G C Pritchard
Journal:  Vet Rec       Date:  2011-05-05       Impact factor: 2.695

3.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

Review 4.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Molecular risk assessment and epidemiological typing of Shiga toxin-producing Escherichia coli by using a novel PCR binary typing system.

Authors:  Stephanie M Brandt; Nicola King; Angela J Cornelius; Aruni Premaratne; Thomas E Besser; Stephen L W On
Journal:  Appl Environ Microbiol       Date:  2011-02-04       Impact factor: 4.792

6.  Serogroups of Escherichia coli isolated from piglets in Spain.

Authors:  J I Garabal; E A González; F Vázquez; J Blanco; M Blanco; J E Blanco
Journal:  Vet Microbiol       Date:  1996-01       Impact factor: 3.293

7.  Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli.

Authors:  Yoshitoshi Ogura; Tadasuke Ooka; Atsushi Iguchi; Hidehiro Toh; Md Asadulghani; Kenshiro Oshima; Toshio Kodama; Hiroyuki Abe; Keisuke Nakayama; Ken Kurokawa; Toru Tobe; Masahira Hattori; Tetsuya Hayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-06       Impact factor: 11.205

8.  Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease.

Authors:  Mohamed A Karmali; Mariola Mascarenhas; Songhai Shen; Kim Ziebell; Shelley Johnson; Richard Reid-Smith; Judith Isaac-Renton; Clifford Clark; Kris Rahn; James B Kaper
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

9.  Virulence genes and molecular typing of different groups of Escherichia coli O157 strains in cattle.

Authors:  István Tóth; Herbert Schmidt; Gábor Kardos; Zsuzsanna Lancz; Kristina Creuzburg; Ivelina Damjanova; Judit Pászti; Lothar Beutin; Béla Nagy
Journal:  Appl Environ Microbiol       Date:  2009-08-14       Impact factor: 4.792

10.  Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology.

Authors:  Alexander Mellmann; Dag Harmsen; Craig A Cummings; Emily B Zentz; Shana R Leopold; Alain Rico; Karola Prior; Rafael Szczepanowski; Yongmei Ji; Wenlan Zhang; Stephen F McLaughlin; John K Henkhaus; Benjamin Leopold; Martina Bielaszewska; Rita Prager; Pius M Brzoska; Richard L Moore; Simone Guenther; Jonathan M Rothberg; Helge Karch
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

View more
  3 in total

1.  Antimicrobial resistance characteristics and fitness of Gram-negative fecal bacteria from volunteers treated with minocycline or amoxicillin.

Authors:  Miranda Kirchner; Muriel Mafura; Theresa Hunt; Manal Abu-Oun; Javier Nunez-Garcia; Yanmin Hu; Jan Weile; Anthony Coates; Roderick Card; Muna F Anjum
Journal:  Front Microbiol       Date:  2014-12-17       Impact factor: 5.640

2.  Characterization of Non-O157 Escherichia coli from Cattle Faecal Samples in the North-West Province of South Africa.

Authors:  Emmanuel W Bumunang; Tim A McAllister; Rahat Zaheer; Rodrigo Ortega Polo; Kim Stanford; Robin King; Yan D Niu; Collins N Ateba
Journal:  Microorganisms       Date:  2019-08-20

3.  A sensitive method for the recovery of Escherichia coli serogroup O55 including Shiga toxin-producing variants for potential use in outbreaks.

Authors:  M Kirchner; E Sayers; S Cawthraw; N Duggett; R Gosling; C Jenkins; T J Dallman; D Mueller-Doblies; M F Anjum
Journal:  J Appl Microbiol       Date:  2019-07-07       Impact factor: 3.772

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.